Pharaonia
Pharaonia

Pharaonia Pharmaceuticals was founded in 1997. It manufactures and markets more than 250 products and 50 products in the pipelines which almost cover all therapeutic groups and dosage forms.​ ​ Pharaonia Pharmaceuticals is one of the top 30 companies among nearly 800 multinational and local pharmaceutical companies and scientific offices.​ ​

CHI
CHI

CHI

La Roche-Posay
La Roche-Posay

Hikma
Hikma

Hikma was founded in 1978 in Amman, Jordan by Samih Darwazah, our current Chairman and CEO. In the early years, the Company’s primary focus was on developing a branded pharmaceuticals business across the MENA Region. Then in the early 1990’s, Hikma expanded outside the MENA Region by acquiring a generic pharmaceuticals business in the United States and by establishing injectable pharmaceutical operations in Portugal. Since then, the company has expanded significantly, both organically and through acquisition.

Unipharma
Unipharma

Unipharma company one of the largest leading companies and specialized in the pharmaceutical industry in Syria, a limited family-owned company was established in 1990 in accordance with the provisions of the Investment Law, the factory buildings were built in the countryside of Damascus, Syria, in accordance with the Good Manufacturing of the drug prescribed by the World Health Organization GMP systems, and in cooperation with the experts from the best pharmaceutical companies in the world, on an area of approximately 10,000 m 2 and enlargement, which began its implementation, which is estimated to be approximately 25,000 m2.

Bristol Mayers Squibb BMS
Bristol Mayers Squibb BMS

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and, rheumatoid arthritis. At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.